Scientists have long known that hormonal shifts during the menopause transition can affect overall health. Early menopause has previously been tied to higher rates of coronary heart disease and stroke, but whether it directly increases hypertension risk has remained uncertain. Earlier meta-analyses have produced conflicting results, partly because the menopause transition often coincides with weight gain and metabolic changes that also raise blood pressure.

To reduce that problem, the researchers used data from the UK Biobank, focusing on 107,836 postmenopausal participants enrolled between 2006 and 2010. Women were followed for a median of nearly 15 years through the end of 2003. Instead of treating menopause as a single event, the team categorized participants by age at menopause—normal (after 45), early (40–45), and premature (before 40)—and also examined natural versus surgical menopause.

Across follow-up, 18,508 women (17.2%) were diagnosed with hypertension. Rates rose as menopause occurred earlier: 16.6% among women with normal timing, 18.8% among those with early menopause, and 22.6% among those with premature menopause. After statistical adjustment for more than 50 factors—including body weight, lifestyle, family history, and laboratory measures—premature menopause still corresponded to a higher risk of developing hypertension.

The investigators then modeled age at menopause on a continuous scale, finding that risk peaked between ages 25 and 35 rather than exactly at the traditional cutoff of 40. This suggests that the biologically relevant exposure window may begin earlier than standard clinical categories imply.

In supplementary analyses, surgical menopause initially showed higher hypertension rates, but the association weakened after accounting for other cardiovascular risk variables. Taken together, the results strengthen the case that the timing of menopause itself—rather than only associated behaviors—may help forecast long-term blood pressure outcomes.

The authors recommend that clinicians consider age at menopause as a distinct cardiovascular risk marker, particularly for women who experience menopause before age 40. They also emphasize earlier blood pressure screening and management as potential opportunities to reduce future cardiovascular burden. Hormone therapy is commonly recommended for premature menopause until the natural age of menopause, unless contraindications exist.

Subject of Research: People
Article Title: Premature menopause is associated with the development of blood pressure: a UK Biobank cohort study
News Publication Date: 29-Jul-2026
Web References: https://menopause.org/wp-content/uploads/press-release/MENO-D-26-00006.pdf ; http://dx.doi.org/10.1097/GME.0000000000000002834
References: 10.1097/GME.0000000000000002834
Image Credits: Not provided
Keywords: premature menopause, hypertension, UK Biobank, cardiovascular risk, Menopause journal

The menopausal transition occurs over several years and is characterized by significant hormonal changes that can lead to various physical and psychological symptoms. Many women experience hot flashes, mood swings, and sleep disturbances, all of which can profoundly impact their quality of life. Despite this, there is often a stark lack of awareness among healthcare professionals regarding how to effectively address these issues. This gap in knowledge signifies a critical area where improvements are both necessary and possible.

The scoping review conducted by Scott and colleagues dives deep into existing literature and current practices related to menopause and healthcare. The research highlights a crucial unmet need for training and education within the healthcare workforce. Many healthcare providers feel ill-equipped to manage menopausal symptoms, leading to insufficient care and support for patients. By identifying this shortfall, the authors aim to advocate for enhanced educational resources targeting menopause management.

Stakeholder consultation is a vital component of this research. By engaging with various stakeholders, including healthcare professionals, patients, and policymakers, the authors sought to capture a comprehensive range of perspectives related to menopause management. These consultations are critical in understanding not only the lived experiences of women undergoing menopause but also the systemic barriers that healthcare providers face in delivering appropriate care.

The results of this research have implications that extend beyond just the healthcare setting. The way society perceives and discusses menopause significantly influences how women experience this stage in their lives. Historically, menopause has often been shrouded in stigma and silence, making it difficult for women to seek assistance and share their experiences openly. By addressing menopause both as a medical and social issue, the authors aim to foster a cultural shift that encourages open conversations and greater empathy within the healthcare workforce.

Moreover, the findings of this review are timely, given the increasing awareness surrounding women’s health issues. There is a growing movement advocating for more attention to be paid to women’s unique health needs, particularly during midlife. By framing menopause within this larger context, Scott et al. emphasize the importance of integrating menopause education into broader women’s health initiatives.

The need for systemic change is evident in many healthcare setups, where menopause is often erroneously seen as a trivial issue. The authors advocate for policies that support comprehensive training programs for healthcare providers, ensuring that they are well-equipped to handle the complexities of menopause. Such changes could drastically improve the care women receive during this significant life change.

As part of their research, Scott and colleagues conducted a thorough examination of current clinical guidelines and best practices. They found that while there are established guidelines available, many practitioners remain unaware of them or do not implement them effectively. This disconnect between existing literature and everyday practices highlights an urgent need for better dissemination of information within healthcare communities.

Additionally, the scoping review provides recommendations for future research directions, emphasizing the importance of continuous learning and adaptation within the healthcare field. Women’s health, particularly in regards to menopause, must remain a dynamic area of study, evolving alongside new evidence and societal changes. By prioritizing research in this area, the healthcare workforce can ensure they are meeting the needs of evolving demographics and changing patient expectations.

The stakeholders consulted during this research expressed a desire for more collaborative efforts among healthcare providers, researchers, and advocacy groups. Many felt that a united front would better serve to address the issues surrounding menopause, creating a more robust support network for women. Through greater collaboration, initiatives can be developed that promote awareness, education, and practical resources for both patients and providers.

Finally, this review stands as a call to action for the healthcare community. The authors encourage healthcare organizations and educators to prioritize menopause in their training programs, ensuring that the next generation of healthcare providers is well-versed in this critical area of women’s health. By doing so, they can create a supportive environment that empowers women to seek help during one of the most challenging transitions of their lives.

In conclusion, Scott, Hancock, Rogers, and their team have laid a significant foundation for addressing the complexities of menopause within the healthcare workforce. Their comprehensive scoping review and stakeholder consultation represent an important step towards transforming the dialogue surrounding menopause from one of stigma to one of support and understanding. Moving forward, it is vital for the healthcare system to embrace these findings and prioritize the health and well-being of women experiencing menopause, thereby improving patient care and outcomes for millions.

Subject of Research: Menopause and its impact on the healthcare workforce

Article Title: Menopause and the healthcare workforce: a scoping review and stakeholder consultation

Article References:

Scott, J., Hancock, J., Rogers, M. et al. Menopause and the healthcare workforce: a scoping review and stakeholder consultation. BMC Health Serv Res (2026). https://doi.org/10.1186/s12913-025-13906-z

Image Credits: AI Generated

DOI: 10.1186/s12913-025-13906-z

Keywords: menopause, healthcare workforce, women’s health, training, stakeholder consultation, scoping review.

The intersection between menopause and mental health has gained more attention in recent years. The hormonal changes that accompany menopause—particularly declines in estrogen and progesterone—are believed to play a significant role in affecting neurotransmitter systems that regulate mood and emotional well-being. Crockett and her colleagues embark on exploring how these hormonal fluctuations can contribute to various mental health issues among menopausal women. Their findings highlight the biological and psychological complexities inherent in this life transition, establishing a need for comprehensive care that addresses both physical and mental health.

In addition to hormonal changes, lifestyle factors such as stress, sleep disturbances, and social dynamics can compound mental health challenges during menopause. The research emphasizes that women experiencing menopause are often also dealing with significant life changes, including career transitions, caregiving responsibilities, and even the onset of age-related health issues. These contextual factors may further predispose women to mental health vulnerabilities, making a multifaceted approach to care essential. Addressing this broader landscape will be critical for clinicians and healthcare providers as they support women during this period.

The role of estrogen in modulating mood has long been recognized, but the exact mechanisms remain an area of active investigation. Through the use of both longitudinal studies and cross-sectional surveys, Crockett et al. provided valuable data linking hormonal levels to self-reported measures of anxiety and depression. This research highlights that fluctuations in hormone levels can lead to increased vulnerability, indicating that hormonal replacement therapies might serve as beneficial interventions for some women experiencing pronounced psychological distress during menopause.

Furthermore, the research reveals that the perception of aging can also play a significant role in women’s mental health during menopause. Societal attitudes toward menopause, aging, and femininity may contribute significantly to how women experience this phase of life. When menopause is stigmatized, women may suffer not only from physical symptoms but also from psychological burdens stemming from societal pressures. By understanding these cultural contexts, healthcare providers can foster an environment that supports women in embracing this transition positively, facilitating healthier adaptations.

The study also points to the importance of support systems and community. Women’s mental health during menopause can be significantly improved when they have access to supportive networks. Social connections—be it family, friends, or peer support groups—provide emotional backup and shared experiences. Engaging in dialogue about common challenges can help normalize these experiences and create a community of understanding and support that combats feelings of isolation and anxiety.

In the digital age, technology offers new avenues for women to access support and information related to menopause. Online forums, social media groups, and telehealth platforms have emerged as valuable resources for women seeking information or community. The findings from this research suggest that digital health interventions could serve as an adjunct to traditional treatment modalities, providing flexible and accessible options for women seeking to manage their mental well-being during menopause.

As we look ahead, there is potential for integrating mental health screenings into routine menopausal care. By routinely assessing mood and emotional well-being as part of women’s health protocols, healthcare providers can be more proactive in identifying at-risk patients and implementing timely interventions. This holistic approach would emphasize the interconnectedness of physical and mental health, ensuring that both aspects receive equal attention during menopausal management.

Furthermore, the economic implications of addressing menopause-related mental health are significant. Women experiencing mental health issues during menopause may face increased healthcare costs, productivity losses, and reduced quality of life. By investing in comprehensive treatment strategies that incorporate both physical and mental health care, we stand to enhance the overall well-being of menopausal women, potentially mitigating long-term costs and improving life satisfaction.

Beyond pharmacological interventions, lifestyle modifications such as diet, exercise, and mindfulness practices can play vital roles in alleviating some mental health challenges associated with menopause. Crockett et al. highlight the importance of resilience-building strategies that empower women to cultivate emotional well-being through holistic approaches. The findings call for an integrative framework that not only addresses symptoms but also promotes overall health and quality of life.

These insights underscore the need for ongoing research to identify the most effective strategies for supporting menopausal women. Engaging diverse populations in future studies will be crucial, as there are variations in experiences based on race, socioeconomic status, and personal background. Such inclusiveness will ensure that care is tailored and relevant, leading to better outcomes for all women navigating menopause.

In conclusion, the future of menopause management lies not just in treating the biological aspects, but in comprehensively addressing the mental health implications as well. As more research emerges, it is imperative for healthcare systems to recognize the importance of integrating mental health care into menopause management. By doing so, we pave the way for improved health outcomes, empowerment, and quality of life for women, allowing them to embrace this stage of life with confidence and resilience.

The upcoming article by Crockett et al. promises to be a significant contribution to our understanding of menopause and mental health, encouraging a much-needed dialogue in both scientific and public spheres. Real change can only happen when we challenge the stigmas surrounding menopause and openly communicate the complexities surrounding women’s health.

From acknowledging hormonal influences to addressing societal perceptions and fostering supportive communities, the findings of this research are crucial. They pave the way for a transformative approach to menopause care that recognizes the intricate interactions between physical and mental health, ultimately leading to better strategies for women everywhere.

Subject of Research: Menopause and its impact on mental health

Article Title: Menopause and Mental Health

Article References:

Crockett, C., Lichtveld, G., Macdonald, R. et al. Menopause and Mental Health.
Adv Ther (2025). https://doi.org/10.1007/s12325-025-03427-w

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s12325-025-03427-w

Keywords: Menopause, mental health, estrogen, hormonal fluctuations, social support, community health, holistic care, resilience, lifestyle modifications.

Multiple sclerosis is a chronic autoimmune disorder characterized by inflammation, demyelination, and subsequent neurodegeneration within the central nervous system. Affecting the immune and nervous systems, MS disproportionately impacts women, with incidence rates approximately three times higher than in men. In Australia alone, about 1 in 800 individuals live with MS, reflecting a substantial public health concern. The disease trajectory varies widely; however, disability progression remains a central concern, especially as patients age.

The intricacies that framed this study arise from the physiological changes women undergo during menopause. At midlife, typically around age 50, women experience a drastic reduction in sex hormones such as estrogen and progesterone. These hormones have been hypothesized to exert neuroprotective effects, potentially modulating MS disease activity. Previous smaller-scale research attempted to delineate the influence of menopause on MS progression but were limited by sample size and heterogeneity, producing inconsistent conclusions regarding whether menopause exacerbates disability.

Associate Professor Vilija Jokubaitis, Deputy Head of Monash University’s School of Translational Medicine Department of Neuroscience, elucidated the rationale behind the investigation. Observational data have noted a point of increased disability progression in MS coinciding with the average age of menopause. Thus, a critical scientific question emerged: does the hormonal milieu shift intrinsic to menopause directly influence the worsening of MS-related disability, or are other aging mechanisms at play? Addressing this required extensive and nuanced data analysis.

Employing data from the MSBase Registry—the largest international clinical outcomes database for MS patients—the research team accessed records for over 120,000 individuals globally, with a focused cohort of 987 Australian women diagnosed with MS. Out of these, 404 participants had undergone menopause. This observational study stands out both in scale and longitudinal follow-up duration, averaging over 14 years per participant, enabling sophisticated temporal assessments of disability trajectories in correlation with menopausal status.

The methodology involved rigorous application of validated disability scoring systems, taking into account confounding factors such as disease-modifying therapies, age-related somatic comorbidities, and lifestyle variables. The researchers employed advanced statistical models to disentangle the potential effects of reproductive aging from general aging processes. Their analyses robustly demonstrated that menopause itself was not independently associated with accelerated disability progression, suggesting that the physiological aging mechanisms unrelated to hormonal decline drive the observed increase in disability measures at midlife.

Dr. Francesca Bridge, the study’s first author and a practicing neurologist specializing in MS, underscored the clinical implications of these findings. “For women navigating both the challenges of MS and the menopausal transition, this study offers critical reassurance,” she stated. Healthcare providers can now better counsel patients, alleviating concerns that menopause might worsen neurological outcomes. This shifts the clinical focus toward managing menopausal symptoms and other modifiable contributors rather than attributing increased disability solely to hormonal changes.

The menopausal period is marked by multiple symptoms such as vasomotor instability (commonly hot flushes), cognitive challenges including memory impairment, mood fluctuations, and urinary dysfunction. Many of these symptoms overlap with existing MS manifestations, complicating management strategies. The elucidation that menopause does not exacerbate MS-related disability enables a more targeted approach to symptom control, emphasizing quality of life improvements through both pharmacological and non-pharmacological interventions.

Comprehensive management models now advocate for holistic approaches addressing lifestyle factors including structured exercise programs, nutritional optimization, and psychosocial support, alongside consideration for menopausal hormone therapy (MHT) where appropriate. These strategies aim to mitigate menopausal symptoms without being overshadowed by fears of accelerating MS disease progression, thus empowering women to maintain functional independence and wellbeing.

The study’s design reflects a mature integration of clinical neurology, epidemiology, and endocrinology. It highlights the importance of large databases like the MSBase Registry, which facilitate cross-institutional collaboration and enable the high-resolution examination of disease courses over extended time frames. Such resources are indispensable for unraveling complex age-related diseases that intersect with reproductive health factors.

Funding support from the National Health and Medical Research Council was instrumental in enabling the data collection and supplementary surveys, which broadened the scope of women’s health considerations in MS research. The collaborative efforts of neuroimmunology centers across Australia underscore a national commitment to advancing understanding in this multifaceted domain, with international studies poised to extend these findings globally.

This research not only refines the clinical narrative surrounding menopause and MS but also opens avenues for further exploration into how other aspects of aging influence autoimmune neurodegenerative diseases. Addressing these dimensions is vital to evolving personalized medicine approaches, where treatment and monitoring protocols are tailored to individual life stages and biological contexts.

In sum, this landmark study dispels the notion that menopause accelerates disability accumulation in women with MS, thereby resolving a longstanding clinical ambiguity. By delineating reproductive aging from somatic aging influences, it charts a clearer path for clinicians and patients alike, emphasizing that the midlife disability surge seen in MS should be understood through the lens of broader age-associated physiological changes rather than hormonal decline alone.

Subject of Research: People

Article Title: Menopause Impact on Multiple Sclerosis Disability Progression

News Publication Date: 29-Sep-2025

Web References:
https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2025.3538

Keywords: Diseases and disorders, Medical specialties

As women age, several biological changes occur that can influence both reproductive capabilities and overall health. The OVA study specifically examines how these aging processes affect cardiovascular risk markers and levels of inflammation. With increasing attention being paid to women’s health issues, this research stands at the forefront of a growing body of literature aimed at better understanding the complex interplay between reproductive health and systemic conditions like heart disease.

Aging ovaries can lead to a range of hormonal changes that impact cardiovascular health. As women approach menopause, decreased estrogen levels may contribute to increased cholesterol levels, changes in vascular function, and heightened inflammatory responses. This transition period is crucial for women, as the risk of cardiovascular diseases often escalates during and after this phase of life. Understanding these changes can empower women to take charge of their health, enabling preventive measures that can mitigate risks associated with aging.

The link between ovarian aging and cardiovascular disease is not merely speculative but is supported by empirical data. The OVA study has mapped out various biomarkers associated with ovarian aging, cardiovascular risk, and inflammation. These metrics provide clinicians and researchers with vital information regarding how a woman’s reproductive system health reflects her overall cardiovascular well-being. It indicates the necessity for routine cardiovascular assessments in women, particularly as they transition into midlife.

Moreover, inflammation has emerged as a central theme in the discussion surrounding ovarian aging and cardiovascular health. Chronic inflammation can significantly impair vascular function and is recognized as a key contributor to heart disease. The researchers of the OVA study have effectively outlined the pathways through which ovarian aging can exacerbate inflammatory processes. Elevated inflammatory markers have been linked to both reproductive aging and heart complications, highlighting a potential area for intervention and treatment.

Understanding the dynamics of estrogen deficiency and its ramifications on health is imperative. Estrogen is not simply a reproductive hormone; it plays a crucial role in maintaining cardiovascular health. The OVA study illustrates that as estrogen production wanes, the body undergoes profound changes that can predispose women to hypertension and other cardiovascular disorders. This knowledge points to the potential benefits of hormone replacement therapies and other interventions tailored to preserve cardiovascular health in aging women.

The implications of this research extend beyond individual health; they carry significant public health considerations. As the global population continues to age, especially in women, the prevalence of cardiovascular disease is expected to rise. By establishing clear correlations between ovarian aging and cardiovascular risk, the OVA study can influence healthcare policies, encouraging the integration of reproductive health perspectives into cardiovascular risk assessments and public health initiatives for women.

Furthermore, the findings encourage a reevaluation of how healthcare providers approach women’s health during different stages of life. Traditionally, discussions about heart health and cardiovascular risks have disproportionately focused on male patients. The insights gained from the OVA study underscore the pressing need for a gender-sensitive approach that recognizes ovarian aging as a critical factor in assessing cardiovascular risk among women.

It is essential to consider these findings within the broader context of lifestyle factors that contribute to both cardiovascular health and ovarian function. Diet, exercise, and stress management play critical roles in modulating the risks associated with aging. The OVA study’s comprehensive analysis provides a framework for future investigations into how lifestyle modifications can improve both reproductive health and cardiovascular outcomes for women.

In conclusion, the revelations from the OVA study signify a pivotal advance in our understanding of the intersection between ovarian aging, cardiovascular risk, and inflammation. By embracing a holistic view of health that incorporates reproductive factors, society can take proactive steps toward empowering women with knowledge and resources to maintain their well-being as they age. This kind of integrative strategy will not only improve individual patient outcomes but also contribute to healthier communities at large.

As researchers continue to unravel the complexities of women’s health, studies like the OVA project form the bedrock of an evolving narrative. These insights are crucial in driving future research directions, fostering collaborations across disciplines, and ultimately enhancing the quality of life for women across the globe. The OVA study symbolizes a beacon of progress in female health research, a call to action for scientists, healthcare providers, and policymakers alike to amplify their focus on the unique health dynamics affecting women as they age.

Remaining vigilant on the evolving landscape of women’s health means acknowledging the profound implications of ovarian aging on cardiovascular risk and systemic inflammation. As more empirical evidence surfaces, we stand at the threshold of a transformative era in women’s health—one that promises to usher in innovative approaches to prevention, therapy, and education. Indeed, the interconnection between reproductive health and cardiovascular disease is an area ripe for exploration and innovation, and the OVA study has undoubtedly set the stage for further inquiry.

Subject of Research: Ovarian aging, cardiovascular risk, and inflammation.

Article Title: Ovarian aging, cardiovascular risk and inflammation: insights from the OVA study.

Article References:

Verhaeghe, C., Lindquist, K., Bleil, M. et al. Ovarian aging, cardiovascular risk and inflammation: insights from the OVA study.
J Ovarian Res 18, 164 (2025). https://doi.org/10.1186/s13048-025-01754-8

Image Credits: AI Generated

DOI: 10.1186/s13048-025-01754-8

Keywords: Ovarian Aging, Cardiovascular Risk, Inflammation, Women’s Health, Estrogen, Hormonal Changes, Heart Disease, Public Health.

The study’s results are particularly salient given the well-documented higher incidence of Alzheimer’s disease among women compared to men. Women are known to be three times more likely to develop this neurodegenerative condition, a phenomenon that is anticipated to intensify as the global population ages. Factors that may contribute to this increased risk include hormonal changes associated with menopause, notably the decline in estradiol levels. This loss of estrogen is suspected to play a critical role in the cognitive health of women as they navigate through midlife and beyond.

In their analysis, the researchers measured the menopausal symptom burden of participants through a comprehensive questionnaire. This assessment included a variety of symptoms such as irregular periods, hot flashes, mood disturbances, sleep issues, memory lapses, and physical changes – all typical experiences during the perimenopausal phase. Notably, the study established a clear correlation between the number of reported symptoms and higher levels of cognitive impairment, quantified by the ECog-II scores, a measure reflecting everyday cognitive function.

The findings were striking: women who endorsed a larger number of perimenopausal symptoms exhibited marked cognitive decline, indicative of potential future dementia risk. The statistical analysis yielded an impressive confidence interval, signifying a robust association, thereby underscoring the potential significance of menopausal experiences in long-term cognitive trajectories. Moreover, the study revealed patterns of mild behavioral impairment, measured by the MBI-C scale, suggesting that psychological well-being during the menopausal transition could critically influence cognitive outcomes later in life.

Another interesting aspect of the study was the exploration of hormone therapy’s role. While no significant relationship between hormone therapy and cognitive function was determined, the researchers noted that hormone therapy appeared to be associated with fewer behavioral symptoms. This revelation opens avenues for further investigation into how estrogen-based treatments might mitigate some psychological challenges faced by postmenopausal women, emphasizing the need for a more nuanced understanding of hormone replacement therapy’s benefits and risks.

The implications of the revealed link between menopausal symptom burden and cognitive decline are twofold. First, they emphasize the importance of early identification and management of menopausal symptoms to protect women’s cognitive function as they age. Second, they highlight the need for subsequent research to verify these findings within diverse populations to strengthen the generalizability of the results. Future studies should ideally incorporate a longitudinal design that could elucidate causal relationships and explore confounding factors such as age of menopause onset, the context of surgical menopause, and individual genetic predispositions.

Furthermore, the authors advocate for a broader dialogue about the experiences of women during menopause, focusing on how these experiences intersect with mental health and cognitive aging. The recognition of menopause as a significant period that can shape long-term health outcomes is a critical step in addressing women’s health issues holistically and incorporating gender-sensitive frameworks in medical research.

In conclusion, the study elucidates a vital connection between the burden of menopausal symptoms and cognitive health, lasting implications for a growing demographic of postmenopausal women. As research continues to unravel the complexities of menopause, it is essential that healthcare providers remain vigilant to the experiences of their female patients, ensuring that menopausal symptom management is part of a strategy designed to safeguard cognitive health and improve quality of life in later years.

The findings serve as a potent reminder of the interconnections between physiological changes and cognitive health, urging society to take note of the unique health challenges faced by women and promote greater awareness and understanding of their needs throughout their life stages.

With this burgeoning field of study gaining recognition, it is incumbent upon both clinical practitioners and researchers to collaboratively address the myriad of challenges posed by menopause, aiming towards innovative solutions that can enhance the overall well-being of older women globally. These insights may ultimately lead to more tailored treatments and preventive strategies that not only address immediate menopausal symptoms but also support long-term cognitive health.

Ultimately, as we garner a deeper understanding of the relationship between menopausal symptoms and cognitive aging, we can foster more informed discussions and interventions, ensuring that women’s voices are heard and their health histories respected as we move forward into a more equitable healthcare landscape.

Subject of Research: Women and cognitive function in relation to menopausal symptoms
Article Title: Menopausal symptom burden as a predictor of mid- to late-life cognitive function and mild behavioral impairment symptoms: A CAN-PROTECT study
News Publication Date: March 5, 2025
Web References: PLOS One Journal
References: Crockford JFE, et al. (2025). PLOS ONE 20(3): e0301165. DOI: 10.1371/journal.pone.0301165
Image Credits: Credit: Crockford et al., 2025, PLOS One, CC-BY 4.0

Keywords: Menopause, cognitive function, behavioral symptoms, Alzheimer’s disease, hormone therapy, women’s health, dementia risk, observational study.